• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

指导基因筛查的政策决策:制定一种系统且透明的方法。

Guiding policy decisions for genetic screening: developing a systematic and transparent approach.

作者信息

Andermann A, Blancquaert I, Beauchamp S, Costea I

机构信息

McGill University, Montreal, Que., Canada.

出版信息

Public Health Genomics. 2011;14(1):9-16. doi: 10.1159/000272898. Epub 2009 Dec 29.

DOI:10.1159/000272898
PMID:20051674
Abstract

With the ever-widening gap between what is technologically possible and services available, jurisdictions around the world are faced with complex decisions regarding the introduction and expansion of genetic screening programs. A series of literature reviews and consultations with stakeholders and experts led to the development of a decision support guide for genetic screening policy-making. This involved establishing a preliminary list of core criteria synthesized from the growing literature on genetic screening, which was then transformed through a series of consultations into a more elaborate decision guide. Although certain perennial challenges in genetic screening policy-making remain, the decision support guide aims to promote a fair and evidence-informed process that makes explicit the ethical dilemmas often inherent to such policy decisions.

摘要

随着技术上可行的事物与可得的服务之间的差距不断扩大,世界各地的司法管辖区在引入和扩大基因筛查项目方面面临着复杂的决策。一系列的文献综述以及与利益相关者和专家的磋商促成了一份基因筛查政策制定决策支持指南的制定。这包括根据关于基因筛查的不断增多的文献建立一份核心标准初步清单,然后通过一系列磋商将其转化为一份更详尽的决策指南。尽管基因筛查政策制定中某些长期存在的挑战依然存在,但该决策支持指南旨在推动一个公平且基于证据的过程,明确此类政策决策中常常固有的伦理困境。

相似文献

1
Guiding policy decisions for genetic screening: developing a systematic and transparent approach.指导基因筛查的政策决策:制定一种系统且透明的方法。
Public Health Genomics. 2011;14(1):9-16. doi: 10.1159/000272898. Epub 2009 Dec 29.
2
Genetic screening: a conceptual framework for programmes and policy-making.遗传筛查:规划和政策制定的概念框架。
J Health Serv Res Policy. 2010 Apr;15(2):90-7. doi: 10.1258/jhsrp.2009.009084. Epub 2010 Feb 22.
3
Using social network analysis to examine the decision-making process on new vaccine introduction in Nigeria.利用社交网络分析研究尼日利亚新疫苗引入决策过程。
Health Policy Plan. 2012 May;27 Suppl 2:ii27-38. doi: 10.1093/heapol/czs037.
4
Addressing the theoretical, practical and ethical challenges inherent in prospective health policy analysis.应对前瞻性健康政策分析中固有的理论、实践和伦理挑战。
Health Policy Plan. 2008 Sep;23(5):351-60. doi: 10.1093/heapol/czn026. Epub 2008 Jul 29.
5
Evidence-based public health: what does it offer developing countries?循证公共卫生:它能为发展中国家带来什么?
J Public Health (Oxf). 2005 Jun;27(2):215-21. doi: 10.1093/pubmed/fdi024. Epub 2005 Apr 8.
6
Factors of the innovation, organization, environment, and individual that predict the influence five systematic reviews had on public health decisions.创新、组织、环境和个体等因素,这些因素预测了五项系统评价对公共卫生决策的影响。
Int J Technol Assess Health Care. 2001 Fall;17(4):467-78.
7
Bioethical decision making: an approach to improve the process.
Med Care. 1979 Nov;17(11):1131-8.
8
Family pediatrics: report of the Task Force on the Family.家庭儿科学:家庭问题特别工作组报告
Pediatrics. 2003 Jun;111(6 Pt 2):1541-71.
9
How do drug policy makers access research evidence?药物政策制定者如何获取研究证据?
Int J Drug Policy. 2009 Jan;20(1):70-5. doi: 10.1016/j.drugpo.2007.11.017. Epub 2008 Jan 15.
10
Five propositions for improving decision making about the environment in developing communities: insights from the decision sciences.关于改善发展中社区环境决策的五个建议:决策科学的见解。
J Environ Manage. 2011 Mar;92(3):363-71. doi: 10.1016/j.jenvman.2010.10.010. Epub 2010 Oct 29.

引用本文的文献

1
Early-Onset Inherited Metabolic Diseases: When Clinical Symptoms Precede Newborn Screening-Insights from Emilia-Romagna (Italy).早发性遗传性代谢疾病:临床症状先于新生儿筛查时——来自意大利艾米利亚-罗马涅地区的见解
Children (Basel). 2025 Apr 4;12(4):464. doi: 10.3390/children12040464.
2
Considering severity in the design of reproductive genetic carrier screening programs: screening for severe conditions.在生殖遗传携带者筛查项目设计中考虑疾病严重程度:严重疾病筛查
Eur J Hum Genet. 2025 Mar;33(2):194-198. doi: 10.1038/s41431-024-01738-0. Epub 2024 Nov 25.
3
Wilson and Jungner Revisited: Are Screening Criteria Fit for the 21st Century?
重温威尔逊和荣格纳:筛查标准是否适用于21世纪?
Int J Neonatal Screen. 2024 Sep 13;10(3):62. doi: 10.3390/ijns10030062.
4
Newborn screening in Germany.德国的新生儿筛查。
Med Genet. 2022 May 7;34(1):1-2. doi: 10.1515/medgen-2022-2119. eCollection 2022 Apr.
5
Australian public perspectives on genomic newborn screening: which conditions should be included?澳大利亚公众对基因组新生儿筛查的看法:应包括哪些条件?
Hum Genomics. 2024 May 8;18(1):45. doi: 10.1186/s40246-024-00611-x.
6
A Delphi Survey Study to Formulate Statements on the Treatability of Inherited Metabolic Disorders to Decide on Eligibility for Newborn Screening.一项德尔菲调查研究,旨在制定关于遗传性代谢疾病可治疗性的声明,以确定新生儿筛查的资格。
Int J Neonatal Screen. 2023 Oct 11;9(4):56. doi: 10.3390/ijns9040056.
7
[Newborn blood spot screening (NBS) in Germany : Status quo and presentation of a concept for further development].[德国新生儿血斑筛查(NBS):现状及进一步发展概念的介绍]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2023 Nov;66(11):1195-1204. doi: 10.1007/s00103-023-03771-8. Epub 2023 Oct 10.
8
Scaling-up and future sustainability of a national reproductive genetic carrier screening program.国家生殖遗传携带者筛查项目的扩大规模及未来可持续性
NPJ Genom Med. 2023 Jul 31;8(1):18. doi: 10.1038/s41525-023-00357-w.
9
Is Our Newborn Screening Working Well? A Literature Review of Quality Requirements for Newborn Blood Spot Screening (NBS) Infrastructure and Procedures.我们的新生儿筛查工作进展顺利吗?新生儿血斑筛查(NBS)基础设施与程序质量要求的文献综述。
Int J Neonatal Screen. 2023 Jun 22;9(3):35. doi: 10.3390/ijns9030035.
10
Are We Ready for Whole Population Genomic Sequencing of Asymptomatic Newborns?我们是否准备好对无症状新生儿进行全人群基因组测序?
Pharmgenomics Pers Med. 2023 Jul 1;16:681-691. doi: 10.2147/PGPM.S376083. eCollection 2023.